U.S. market Closed. Opens in 1 day 7 hours 2 minutes

NBY | NovaBay Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue14.73M14.40M8.42M9.93M6.60M
Cost of Revenue6.83M6.62M2.78M3.97M1.74M
Gross Profit7.89M7.78M5.64M5.96M4.86M
Operating Expenses12.90M15.46M14.51M12.39M14.26M
Selling, General & Admin12.83M15.29M14.46M12.11M14.08M
Research & Development68.00K174.00K44.00K285.00K184.00K
Other Operating ExpensesN/A-276.00K-1.58M605.00K-1.43M
Operating Income-5.00M-7.68M-8.86M-6.43M-9.40M
Other Expenses / Income-4.64M-2.78M3.04M-4.61M-252.00K
Before Tax Income-9.64M-10.61M-5.82M-11.03M-9.65M
Income Tax ExpensesN/A-3.81M-4.62M5.00K6.00K
Net Income-9.64M-16.27M-6.56M-11.04M-10.49M
Interest ExpensesN/AN/AN/AN/A1.05M
Basic Shares Outstanding120.43K30.00K31.64K28.63K16.27K
Diluted Shares Outstanding120.43K46.00K35.63K28.63K17.67K
EBITDA-4.80M-7.20M-8.74M-6.38M-9.34M
EBITDA Margin-32.60%-49.97%-103.82%-64.17%-141.46%
EBIT-9.64M-20.07M-11.17M-11.03M-9.43M
EBIT Margin-65.46%-139.36%-132.69%-111.07%-142.87%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙